326 related articles for article (PubMed ID: 20080953)
21. Involvement of nuclear steroid/thyroid/retinoid receptors and of protein kinases in the regulation of growth and of c-erbB and retinoic acid receptor expression in MCF-7 breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Breast Cancer Res Treat; 1999 Nov; 58(2):171-81. PubMed ID: 10674883
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
[TBL] [Abstract][Full Text] [Related]
23. [Growth inhibitory effect of retinoic acid in human breast cancer cells correlates with retinoic acid receptor alpha (RAR alpha) expression].
Yu L; Shao Z; Cai S
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):429-32. PubMed ID: 9387294
[TBL] [Abstract][Full Text] [Related]
24. Retinoid receptors: pathways of proliferation inhibition and apoptosis induction in breast cancer cell lines.
Raffo P; Emionite L; Colucci L; Belmondo F; Moro MG; Bollag W; Toma S
Anticancer Res; 2000; 20(3A):1535-43. PubMed ID: 10928067
[TBL] [Abstract][Full Text] [Related]
25. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of estrogen receptor-positive human breast carcinoma cell growth by retinoic acid].
Shao Z; Yu L; Jiang M
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):245-8. PubMed ID: 11038749
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid nuclear receptor alpha(RAR alpha) plays a major role in retinoid-mediated inhibition of growth in human breast carcinoma cells.
Shao Z; Yu L; Shen Z; Fontana JA
Chin Med Sci J; 1996 Sep; 11(3):142-6. PubMed ID: 9387397
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo interactions between nuclear receptors at estrogen response elements.
Joyeux A; Balaguer P; Gagne D; Nicolas JC
J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):507-15. PubMed ID: 8918976
[TBL] [Abstract][Full Text] [Related]
29. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
30. A tumour suppressive relationship between mineralocorticoid and retinoic acid receptors activates a transcriptional program consistent with a reverse Warburg effect in breast cancer.
Doan TB; Cheung V; Clyne CD; Hilton HN; Eriksson N; Young MJ; Funder JW; Muscat GEO; Fuller PJ; Clarke CL; Graham JD
Breast Cancer Res; 2020 Nov; 22(1):122. PubMed ID: 33148314
[TBL] [Abstract][Full Text] [Related]
31. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
Martini PG; Katzenellenbogen BS
Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity.
van der Leede BM; Geertzema J; Vroom TM; Décimo D; Lutz Y; van der Saag PT; van der Burg B
Am J Pathol; 1996 Jun; 148(6):1905-14. PubMed ID: 8669476
[TBL] [Abstract][Full Text] [Related]
33. Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.
Morrison AJ; Herrera RE; Heinsohn EC; Schiff R; Osborne CK
Mol Endocrinol; 2003 Aug; 17(8):1543-54. PubMed ID: 12730327
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
35. Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.
Fettig LM; McGinn O; Finlay-Schultz J; LaBarbera DV; Nordeen SK; Sartorius CA
Oncogene; 2017 Nov; 36(44):6074-6084. PubMed ID: 28692043
[TBL] [Abstract][Full Text] [Related]
36. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
[TBL] [Abstract][Full Text] [Related]
38. Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer.
Chung YL; Sheu ML; Yang SC; Lin CH; Yen SH
Int J Cancer; 2002 Jan; 97(3):306-12. PubMed ID: 11774281
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
Viswakarma N; Nair RS; Sondarva G; Das S; Ibrahimi L; Chen Z; Sinha S; Rana B; Rana A
Oncotarget; 2017 May; 8(20):33172-33184. PubMed ID: 28388540
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand.
Niwa T; Takanobu J; Suzuki K; Sato Y; Yamaguchi Y; Hayashi SI
J Steroid Biochem Mol Biol; 2020 Jul; 201():105671. PubMed ID: 32289430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
